Archive

Category Archives for "Press Releases"

Sichenzia Ross Friedman Ference LLP Acted as Placement Agent Counsel on MabVax Therapeutic’s $11.7M PIPE

mabvax therapeutics

New York, NY – April 17, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that Axiom Capital Management Inc. has completed a private placement of MabVax Therapeutics Holdings, Inc. (OTC: MBVX) Units. MabVax is a clinical-stage biopharmaceutical company focused on developing vaccine and monoclonal anti-body based therapeutics. continue reading >>

Sichenzia Ross Friedman Ference LLP Advises Citius Pharmaceuticals, LLC on $270,000 PIPE Financing

citius pharma

New York, NY — March 26, 2015 — Global Newswire — New York based securities law firm Sichenzia Ross Friedman Ference LLP announced that the Firm represented Citius Pharmaceuticals, LLC (OTCQB: CTXR), a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets, in connection with a $270,000 PIPE transaction. continue reading >>

IBI Times Covers Partner Marc J. Ross’ Marijuana Business Law Class

New York, NY, March 24, 2015 – The International Business Times recently published an article discussing the marijuana business law course currently taught by Marc R. Ross, Esq., founding partner of Sichenzia Ross Friedman Ference LLP, at Hofstra University School of Law. The article, titled Amid Marijuana Legalization Efforts, US Law Schools Offer Pot Courses,” discusses a recent class which “focused on dissecting the tricky legal and policy issues related to legalized cannabis,” continue reading >>

Partner Marc J. Ross Speaks at Another Accredited Marijuana Symposium on the Financial Implications to Marijuana-Related Businesses & NY’s Compassionate Care Act

Hempstead, New York – March 12, 2015 – Global Newswire – Marc J. Ross, founding partner of Sichenzia Ross Friedman Ference LLP, was a featured presenter at Hofstra University School of Law’s symposium: “Puff the Magic Medicine – The Medical Marijuana Movement. The forum, which was both CLE and CME accredited, was part of the ongoing Garfunkel Wild Thought Leadership in Action Speaker Series, and examined the existing conflict between state and federal marijuana laws, continue reading >>

Sichenzia Ross Friedman Ference LLP Advises Solar3D on $12.5M Public Offering of Units and Uplisting to the NASDAQ Capital Market

solar 3d

March 6, 2015 – New York, NY – (Global Newswire) – Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Solar3D, Inc. (NASDAQ: SLTD), a provider of solar power solutions and the developer of a proprietary high efficiency solar cell, on a public offering of 3,000,000 units. continue reading >>

Contravir Pharmaceuticals, Inc. Announces Uplisting to NASDAQ Capital Market

contravir

Sichenzia Ross Friedman Ference LLP Advises ContraVir Pharmaceuticals on NASDAQ Uplisting

New York, NY – February 27, 2015 – (Global Newswire) – Nationally recognized securities andContra Contra
corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), a biopharmaceutical company focused on the discovery and development of antiviral therapies, in the Company’s uplisting to the NASDAQ Capital Market. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Sole-Book Running Manager in $3.0M Public Offering for CollabRX

collab rx

Sichenzia Ross Friedman Ference LLP Advises Aegis Capital Corp. on $3.0 Million Public Offering of CollabRX, Inc.

New York, NY – February 26, 2015 — (GLOBE NEWSWIRE) — New York- based securities law firm Sichenzia Ross Friedman Ference LLP announced that it has represented Aegis Capital Corp. as the sole book-running manager of a $3 million public offering for CollabRX, Inc. (NASDAQ: CLRX), a provider of cloud-based expert systems designed to inform healthcare decision-making. continue reading >>

Orbital Tracking Corp. Announces Share Exchange Agreement with Global Telesat & $1.1M PIPE

orbital tracking corp

Sichenzia Ross Friedman Ference LLP Advises Orbital Tracking Corp. in Share Exchange Agreement and $1.1 Million PIPE Financing

New York, NY – February 26, 2015 – (Global Newswire) – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Orbital Tracking Corp. (OTCQB: TRKK), a global satellite services entity, in a share exchange agreement with Global Telesat Communications Limited, a privately held United Kingdom corporation (“GTCL”) and the shareholders of GTCL. continue reading >>

Sichenzia Ross Friedman Ference LLP Advises Aegis Capital Corp. as Sole Book-Running Manager on $5.52M Public Offering of CollabRX, Inc.

collab rx

NY, New York – February 25, 2015 – Global Newswire—Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Aegis Capital Corp. as the sole book-running manager in a $5,520,000 public offering for CollabRX, Inc. (NASDAQ: CLRX),  a provider of cloud-based expert systems for selecting clinical treatments. continue reading >>

Partner Gregory Sichenzia Interviewed by TheStreet.com on Baidu’s Stock Growth Potential

February 23, 2015 – Financial news and services website TheStreet.com recently interviewed Sichenzia Ross Friedman Ference LLP Gregory Sichenzia on the stock growth potential for investors of Baidu, China’s largest search engine provider.

Baidu has long been touted as the “Chinese Google” and when asked to compare the two major companies, Mr. Sichenzia said:

“You can still buy Baidu relatively cheaply at a $76 billion market capital and that it is projected to experience 41 percent growth in 2015 while Google is quite expensive at $360 billion market cap with smaller growth potential for 2015,” said Gregory Sichenzia, a founding member of Sichenzia Ross Friedman Ference. “For this reason, Baidu is the better buy for stock investors, as Google, being a more mature company, is limited in upside for investors.”

Read the rest of the article here

Gregory Sichenzia, Esq.

Gregory Sichenzia, Esq.

Gregory Sichenzia, a founding member, counsels public and private companies in all securities laws matters, from complex financing transactions and listings on various stock exchanges through everyday regulatory requirements. He has also been responsible for structuring innovative merger and acquisition transactions. Throughout his career he has represented many companies and investment banks in initial public offerings of securities, and has represented numerous public companies in private equity financing transactions (“PIPEs”) and the resulting resale regist
Gregory Sichenzia, Esq.

Latest posts by Gregory Sichenzia, Esq. (see all)

    Sichenzia Ross Friedman Ference LLP Represents Laidlaw & Company (UK) Ltd. on a $20.0 Million Public Offering of Actinium Pharmaceuticals, Inc.

    actinium pharmaceuticals

    February 12, 2015 – New York, NY – (Global Newswire) – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as the sole book-running manager in an underwritten public offering for Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM), a biopharmaceutical company developing innovative targeted immunotheraputics for the treatment of advanced cancers. continue reading >>

    Sichenzia Ross Friedman Ference LLP Advises Trovagene Inc. on a $23.0M Public Offering

    trovagene

    New York, NY – February 11, 2015 – (Global Newswire) – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, in an underwritten public offering of 5,111,110 shares of the company’s common stock. continue reading >>

    Sichenzia Ross Friedman Ference LLP Represents Tonix Pharmaceuticals in $28.7M Public Offering

    tonix pharmaceuticals

    New York, NY – February 10, 2015 – (Global Newswire) – New York-based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm represented Tonix Pharmaceuticals Holding Corp., a clinical-stage pharmaceutical company, in an underwritten public offering of 4,900,000 shares of common stock at a price of $5.85 per share. continue reading >>

    Partner Marc J. Ross Interviewed by International Business Times on Colorado’s Unique Marijuana Tax Problem

    February 10, 2015 – The International Business Times recently interviewed Marc J. Ross, founding partner of Sichenzia Ross Friedman Ference LLP, on the unique tax situation that Colorado now faces after earning more than $50 million in revenue from marijuana sales last year. Due to a 1992 constitutional amendment, the state has a limit on how much tax money the state can take in. continue reading >>

    Full Swing Golf Announces Endorsement Deal with Tiger Woods

    full swing golf

    Sichenzia Ross Friedman Ference LLP Represents Full Swing Golf, Inc. in an Endorsement Deal with Tiger Woods

    New York, NY – January 23, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) is pleased to announce that the Firm has represented San Diego-based golf simulator producer Full Swing Golf, Inc., a privately held company, in an endorsement agreement with golf icon Tiger Woods. continue reading >>

    Sichenzia Ross Friedman Ference LLP Recognized As Number One PIPE Issuer Law Firm for 2014

    Ranked Nation’s Leader in PIPEs Transactions Since 2004 – Also Recognized as Leading Investor and Placement Agent Counsel

    New York, NY – January 15, 2015 – Sichenzia Ross Friedman Ference LLP (“SRFF”) has again earned the title of the number one PIPE issuer law firm in the nation, as ranked by industry league tables: Sagient Research’s PlacementTracker and The Deal’s PrivateRaise. 2014 marked the 10th consecutive year that the firm has ranked #1 in both league tables. SRFF was also ranked a national leader in representing investors and placement agents, by volume of deals advised.

    According to PrivateRaise, SRFF represented issuers in 39 PIPE transactions totaling $253.15 million for an average of $6.49 million per transaction in 2014. Since 2004, when the firm was initially ranked as the #1 PIPE law firm in the country, SRFF has completed approximately 550 such transactions valued at more than $4.0 billion.

    Additionally, Placement Tracker recorded that SRFF advised issuers on 25 PIPE transactions amounting to $149.7 million in 2014.

    Media Contact:
    pr@srfkllp.com
    (212)-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Marc J. Ross Teaches First Law School Course on the Business and Legal Issues Related to Marijuana

    NEW YORK, New York — January 8 — Sichenzia Ross Friedman Ference LLP is pleased to announce that founding partner Marc J. Ross will be teaching the first-ever marijuana business and law course at Hofstra University’s School of Law starting in January 2015.  Mr. Ross is a leading authority involving the issues surrounding the marijuana legalization debate and the continue reading >>

    Vuzix Corp. Announces $24.8M Investment from Intel

    vuzix

    Sichenzia Ross Friedman Ference LLP Represents Vuzix Corp. in $24.8M Investment From Intel

    NEW YORK, NY –( January 5, 2015) –New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm represented Vuzix® Corporation (OTCQB: VUZI) (“Vuzix” or the “Company”), a leading supplier of video eyewear and smart glasses products, in an investment transaction whereby Intel Corporation made a $24.8 million investment in Vuzix. Intel’s investment will be used for general working capital and will contribute to the acceleration of the introduction of Vuzix’s next generation wearable display products into the consumer market.

    Intel purchased 49,626 shares of Vuzix’s Series A Preferred Stock, convertible into 4,962,600 shares of the Company’s common stock at an initial conversion price of $5.00 per share. The shares issuable on conversion of the Series A Preferred Stock represent approximately 30% of Vuzix’s outstanding stock.

    The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia, Thomas A. Rose, Tara Guarneri Ferrara and Associate Jeffrey Cahlon.

    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a securities and corporate law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. The firm’s clients range from start-ups to established, listed companies; they include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. The firm also advises institutional investors on transactions involving complex securities law considerations and its practice includes the representation of clients located in the United States and throughout the world. To learn more about Sichenzia Ross Friedman Ference LLP, visit www.srff.com, SRFF’s LinkedIn and SRFF’s Twitter: @SRFFLLP.

     

    PlasmaTech Announces $14.0 M Public Offering and NASDAQ Listing

    plasmatech biopharmaceuticals

    New York, NY – December 24, 2014 – Press Release: New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm  represented H.C. Wainwright & Co. and Aegis Capital Corp. as underwriters in PlasmaTech Biopharmaceuticals, Inc.’s public offering of 3,500,000 shares of common stock and 3,500,000 warrants. The gross proceeds from the offering were $14,035,000 and the offering price was $4.00 per share and $.01 per warrant. The warrants have a per share exercise price of $5.00 and are exercisable immediately.  PlasmaTech common stock and warrants began trading on the NASDAQ Capital Market (effective December 19, 2014) under the symbols “PTBI” and “PTBIW” respectively.

    PlasmaTech Biopharmaceuticals, Inc. is a biopharmaceutical company focused on advanced targeted treatments for critical patient care. The Sichenzia Ross Friedman Ference LLP team was led by Partners Jeffrey J. Fessler and Marcelle Balcombe.

    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

     

    Partner Ben Tan Recognized as Finance Monthly’s 2014 Deal Maker of the Year

    Ben TanSichenzia Ross Friedman Ference LLP is pleased to announce that Partner Ben Tan has been selected as the 2014 Deal Maker of the Year for his representation of Hong Kong Takung Assets and Equity of Artworks Exchange in their  reverse merger with Cardigant Medical Inc.

    Now in its fourth year, the Finance Monthly Deal Maker Awards have quickly gained a reputation as an industry standard for recognising excellence in corporate finance transactions and acknowledge and reward the individuals and firms involved – the bankers, venture capitalists, lawyers, accountants and professional advisors who initiate, structure and negotiate deals for growing organisations.

    Visit here to learn more about the Hong Kong Takung reverse merger and to read about Mr. Tan’s award.

    Great West Resources Inc. Announces Purchase of Globalstar Contracts

    great west resources

    Sichenzia Ross Friedman Ference LLP Advises Great West Resources, Inc. on Purchase of Globalstar Contracts from Global Telesat Corp. and Related License Agreement

    New York, NY – December 29, 2014 – (Global Newswire): New York based securities law firm Sichenzia Ross Friedman Ference LLP announced that it has advised Great West Resources, Inc. (OTCQB: GWST) on the purchase of mobile, satellite and data network contracts from Global Telesat Corp. (“GTC”), a subsidiary of World Surveillance Group, Inc. The contracts permit Great West to utilize the Globalstar Inc. and Globalstar LLC mobile, satellite, voice and data network. GTC also granted to Great West a fully-paid and irrevocable non-exclusive license to use certain equipment owned by GTC or its affiliates consisting of “appliques” in connection with the Globalstar Contracts.  The purchased contracts and license agreement will allow Great West entry into the satellite voice and data sales and services industry.

    The Sichenzia Ross Friedman Ference LLP team was led by Partner Harvey Kesner and Associate Avital Even-Shoshan.

    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

     

    Medovex Corp. Announces $8.0 M IPO

    medovex corp

    Sichenzia Ross Friedman Ference LLP Represents Medovex Corp. in $ 8.0M Initial Public Offering

    New York, NY – December 29, 2014 – Global Medovex NasdaqNewswire – New York based securities law firm Sichenzia Ross Friedman Ference LLP announced that the Firm has represented Medovex Corporation (NASDAQ: MDVXU), a producer of medical device products, in an initial public offering of 1,391,305 units. Each unit consisted of one share of common stock and one Series A Warrant at a price of $5.75 per unit. The IPO resulted in gross proceeds of $8,000,003 to the Company. The IPO was underwritten by Laidlaw & Company (UK) LTD.

    The units trade on the NASDAQ Capital Markets under the symbol “MDVXU” and the common stock and warrants will trade under the symbols “MDVX” and “MDVXW”, respectively on separation.

    Medovex is developing and commercializing the DenerVex® device, which is used in the treatment of conditions resulting from the degeneration of joints in the spine that cause back pain. In 2013, Medovex entered into a Co-Development Agreement with Dr. James Andrews, a renowned orthopedic surgeon who also is a director of the Company. Additionally Medovex intends to seek out acquisition opportunities through its world class Board of Directors which also includes Steve Gorlin, Major General C.A. “Lou” Hennies and Dr. Scott M. W. Haufe.

    The Sichenzia Ross Friedman Ference LLP team was led by Partners Harvey Kesner, Arthur S. Marcus and Associate Marc J. Adesso.

    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

    SBI Investments Announces $6.5 Million Private Placement

    sbi investments

    Sichenzia Ross Friedman Ference LLP Represents SBI Investments in $6.5M Private Placement

    New York, NY (Global Newswire – Dec. 23, 2014) New York-based securities law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented SBI Investments LLC, a private investment firm whose primary focus is to provide creative and alternative funding solutions to global micro-, small- and mid-cap publicly-traded companies, in a private placement of LLC membership interests valued at $6,525,000.

    The Sichenzia Ross Friedman Ference LLP team was led by Partner Darrin Ocasio and Associate Marc Adesso.

    About Sichenzia Ross Friedman Ference LLP

    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages

     

    Sichenzia Ross Friedman Ference LLP Announces Three New Partners for 2015

    New York, NY – (December 23, 2014) – Sichenzia Ross Friedman Ference LLP (“SRFF”), the nationally ranked leading securities and corporate law firm, is pleased to announce today that it has elected three new partners from its attorney ranks. The partnership promotions will be effective starting January 1, 2015.

    We are pleased to welcome three outstanding partner additions for the upcoming new year.” said senior partner Gregory Sichenzia, “These attorneys represent some of the best legal talent in the field of securities and corporate law. Over the years, they have consistently demonstrated legal excellence and shown themselves as experts in a specialized and complex space. We are proud to call them our partners.”

    Sichenzia Ross Friedman Ference LLP’s new partners will include:

    Daniel Scott Furst: Mr. Furst joined the Firm in March 2010. His practice Scott Furstconcentrates on generalcommercial and securities litigation; including arbitration in state and federal courts before regulatory agencies and arbitration tribunals including the Securities and Exchange Commission, Financial Regulatory Authority, and the American Arbitration Association. Mr. Furst specializes in representing public and private companies, broker-dealers, registered representatives and investors.

    Tara Guarneri-Ferrara: Ms. Guarneri-Ferrara focuses her practice in the areas of Tara Guarneri Ferrarasecurities, corporate finance law and mergers and acquisitions. Since her start at SRFF in February 2008, Ms. Guarneri-Ferrara has advised clients in connection with private placements, PIPE transactions, corporate documents and filings and M&A transactions. Ms. Ferrara was also recognized as a 2014 New York Metro Super Lawyers Rising Star.

    Stephen A. Cohen: Mr. Cohen joined SRFF in April 2006. He specializes in representing Steve Cohen issuers and underwriters in corporate finance transactions, mergers and acquisitions and securities law matters. He advises clients on public and private offerings, direct transactions as well as on the formation of private equity hedge funds. Mr. Cohen additionally advises corporations and their boards on securities law compliance, corporate governance and assists them in their periodic reporting requirements. Mr. Cohen was also named by New York Metro Super Lawyers as a 2014 Rising Star.

    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

     

    Can-Fite Biopharma Ltd. Announces $8.0 M At-The-Market Registered Direct Offering

    can-fite biopharma

    Sichenzia Ross Friedman Ference LLP Advises Can-Fite Biopharma Ltd. On A $8.0 M At-The-Market Registered Direct Offering

    New York, NY – (Global Newswire) – 12/20/2014 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Israeli biopharmaceutical company, Can-Fite Biopharma Ltd. (TASE: CFBI; NYSE MKT: CANF) on an at-the-market registered direct offering of for gross proceeds of $8,000,000. The Sichenzia Ross Friedman Ference LLP team was led by Partner Gregory Sichenzia, Associates Gary Emmanuel and Avital Even-Shoshan. H.C. Wainwright & Co., LLC acted as the Placement Agent in the offering.
    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

    Partners Gregory Sichenzia and Thomas A. Rose Admitted to Supreme Court Bar

    With Dean Supreme CourtSichenzia Ross Friedman Ference LLP Partners Gregory Sichenzia and Thomas A. Rose was admitted to the Supreme Court Bar on Tuesday, December 9, along with several other notable Benjamin N. Cardoza alumni. Admission to the United States Supreme Court is an honorable distinction for attorneys of good standing and who have been practicing for more than three years. Upon admission, Mr. Sichenzia and Mr. Rose are granted the exclusive ability to argue before the justices of the Supreme Court. Every attorney admitted to the Supreme Court must be sponsored by two attorneys who have been admitted to the Supreme Court Bar. Mr. Sichenzia and Mr. Ross are sponsored by Matthew Diller, the dean of the Benjamin N. Cardoza Law School and Michael Ference, a partner at Sichenzia Ross Friedman Ference LLP.

     

    Gallery:

    With Justice Scalia
    Partners with Justice Scalia

     

    Supreme Court

     

    Solar3D Retains Sichenzia Ross Friedman Ference As SEC Counsel

    Sichenzia Ross Friedman Ference LLP to Advise the Company on Securities Related Matters and for Potential Uplisting to a Senior Exchange

    SANTA BARBARA, CA — (Marketwired) — 12/04/14 — Solar3D, Inc.(OTCQB: SLTD), a leading solar power company and the developer of a proprietary high efficiency solar cell, today announced that it has retained Sichenzia Ross Friedman Ference LLP (www.srff.com) to represent SLTD on general securities matters and a potential uplisting to a senior exchange.

    Sichenzia Ross Friedman Ference LLP is the top ranked securities law firm as recognized by industry league tables. The firm’s services include but are not limited to providing oversight for stock exchange listing matters, initial and secondary public offerings, alternative public offerings, private investment  in public equity (PIPE) transactions, as well as mergers and acquisitions.

    In early 2014, the company acquired SUNworks, a Sacramento-area solar design and installation firm. Last month, Solar3D agreed to acquire MD Energy, a California-based solar construction firm.

    “We are thrilled to be working with Sichenzia Ross Friedman Ference,” said Jim Nelson, CEO of Solar3D. “Led by Gregory Sichenzia, this firm will act as our securities law partner and will play an important role as we continue to experience substantial growth and pursue new opportunities in the public equity space. The firm’s experience and track record as a strategic partner for growth companies seeking to achieve the next level of development will be very helpful, as Solar3D continues to pursue its aggressive plan for growth in 2015.”

    About Sichenzia Ross Friedman Ference LLP

    Sichenzia Ross Friedman Ference LLP provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters.

    The firm’s clients range from start-ups to established, listed companies. They include private and public corporations,
    partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. Sichenzia Ross also advises institutional investors on transactions involving complex securities law considerations.

    To learn more, visit http://srfkllp.com.

    About Solar3D, Inc.
    Solar3D is a leading provider of solar power solutions and the developer of a proprietary high efficiency solar cell. The company’s
    SUNworks division focuses on the design, installation and management of solar power systems for commercial, agricultural and residential customers. SUNworks is one of the fastest growing solar systems providers in California and has delivered hundreds of 2.5 kilowatt to 1-megawatt commercial systems and has the capability of providing systems as large as 25 megawatts. Solar3D’s technology division is developing a patent-pending 3-dimensional solar cell technology to maximize the conversion of sunlight into electricity. The Solar3D Cell collects sunlight from a wide angle and lets light bounce around in 3-dimensional microstructures on the solar cell surface. The Company’s mission is to further the widespread adoption of solar power by deploying affordable, state-of-the-art systems and developing breakthrough new solar technologies.

    To learn more about Solar3D, visit our website at
    http://www.Solar3D.com.

    DelMar Pharmacueticals Retains Sichenzia Ross Friedman Ference as Their Designated Advisor for Disclosure on OTCQX Exchange

    DMPI-300

    Sichenzia Ross Friedman Ference LLP Serves as DelMar Pharmacueticals ‘ Designated Advisor for Disclosure on OTCQX Exchange

    PRESS RELEASE – December 2, 2014 — Global Newswire

    New York based securities and corporate law firm, Sichenzia Ross Friedman Ference LLP announced today that it has served DelMar Pharmaceuticals Inc. (OTCQX: DMPI), a clinical and commercial stage drug development company, as their Designated Advisor for Disclosure (“DAD”) on their listing on the OTCQX marketplace exchange.

    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

    Synergy Pharmaceuticals Inc. Raises $200M Rule 144A Offering of 7.50% Convertible Senior Notes

    synergy pharmaceuticals

    Sichenzia Ross Friedman Ference LLP Represents Synergy Pharmaceuticals Inc. in $200M Rule 144A Offering of 7.50% Convertible Senior Notes

    New York, NY – (Global Newswire, November 5, 2014) – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced that it  represented Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), a biopharmaceutical developer of drugs to treat gastrointestinal disorders and diseases, in a Rule 144A offering of $200 million of 7.50% Convertible Senior notes. The notes are convertibles into shares of Synergy Pharmaceutical’s common stock at a conversion price of approximately $3.11 per share.

    The SRFF team was led by Partner Jeffrey J. Fessler.

    About Sichenzia Ross Friedman Ference LLP

    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

    Sichenzia Ross Friedman Ference Advises MV Agusta on Partnership with Mercedes-AMG

    mv-augusta

    Sichenzia Ross Friedman Ference LLP Represents MV Agusta on Partnership with Mercedes-AMG

    New York, NY – (Global Newswire, November 3, 2014) – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced that it represented the U.S. subsidiary of MV Agusta, an Italian motorcycle manufacturer, on the negotiation of a cooperation agreement for a long-term partnership with sports-car and performance brand Mercedes-AMG of the Daimler AG. Pursuant to the partnership, which is subject to approval of the relevant European authorities, Mercedes-AMG will acquire a 25% interest in MV Agusta and Mercedes-AMG will appoint one member of MV Agusta’s board of directors. As a 100% subsidiary of Daimler AG, Mercedes-AMG GmbH is the sports-car and performance brand of Mercedes-Benz Cars. Through the sales and marketing partnership with Mercedes-AMG, MV Agusta expects to accelerate company growth and to widen its customer base worldwide.

    The Sichenzia Ross Friedman Ference LLP team was led by Associate Marc J. Adesso.

    Media Contact:

    pr@srfkllp.com

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Blacksands Petroleum Announces Private Placement of $1.0 Million

    Sichenzia Ross Friedman Ference LLP Represents Blacksands Petroleum on a Private Placement of $1.0 Million of Series C Convertible Preferred Stock

    New York, NY – – (Global Newswire – November 3, 2014) – New York-based securities law firm Sichenzia Ross Friedman Ference LLP announced that it represented Blacksands Petroleum, Inc. (OTCQB: BSPE), an oil and gas exploration and production company, in a PIPE transaction with an accredited investor, whereby Blacksands sold 1,000,000 shares of Series C Convertible Preferred Stock, at a purchase price of $1.00 per share. The aggregate value of the offering was $1,000,000.

    The Sichenzia Ross Friedman Ference LLP team was led by Partner Marc J. Ross, Partner James M. Turner and Associate Sharon A. Carroll.

    About Sichenzia Ross Friedman Ference LLP

    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

    CEL-SCI Corporation Announces $6.0 Million Public Offering

    cel sci

    Sichenzia Ross Friedman Ference LLP Represents CEL-SCI Corporation on $6.0 Million Public Offering

    New York, NY – October 29, 2014 – GLOBAL NEWSWIRE – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced that it has advised Laidlaw & Co. (UK) Ltd. as the Lead Underwriter in a $6 million public Public Offering of CEL-SCI Corporation (NYSE MKT: CVM), a late-stage biotechnology company focused on oncology research and drug development. The underwriting was pursuant to a prospectus supplement to an effective S-3 registration statement. The offering consisted of common stock and warrants at a combined price of $0.76 per unit. Pursuant to the offering, CEL-SCI issued one warrant to purchase common stock for every four shares sold. The warrants have an exercise price of $1.25 per unit. The Sichenzia Ross Friedman Ference LLP team was led by Partner Richard A. Friedman and Associate Stephen Cohen.

    About Sichenzia Ross Friedman Ference LLP

    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

    ContraVir Pharmaceuticals Announces $9.0 Million Private Placement

    contravir

    Sichenzia Ross Friedman Ference LLP Advises ContraVir Pharmaceuticals on $9.0 Million Private Placement

    New York, October 28, 2014 (Global Newswire) – New York based securities law firm Sichenzia Ross Friedman Ference LLP announced that it has represented ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, on a $9 million private placement consisting of Series A Convertible Preferred stock to a non-U.S investor.

    Pursuant to the private placement, the Series A Preferred Stock can be converted into shares of common stock at the conversion price of $0.48 per share. The Sichenzia Ross Friedman Ference LLP team was led by partner Jeffrey J. Fessler.

    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

    HongKong Takung & Equity of Artworks Exchange Announces Reverse Merger With Cardigant Medical

    Sichenzia Ross Friedman Ference LLP Advises HongKong Takung Assets and Equity of Artworks Exchange Co. Ltd., on a Reverse Merger with Cardigant Medical Inc.

    Press Release – October 28, 2014 (Global Newswire) – New York-based securities law firm, Sichenzia Ross Friedman Ference LLP, announced that it has represented HongKong Takung Assets and Equity of Artworks Exchange Co.,Ltd. (“Takung”), a Hong Kong-based online platform for artists, art dealers and art investors to trade valuable artwork, in a reverse merger with U.S. company, Cardigant Medical, Inc. (“Cardigant”). The reverse merger was completed on October 20, 2014.

    Pursuant to the reverse merger, Cardigant l acquired all the issued and outstanding capital stock of Takung and in exchange, Takung shareholders acquired 209,976,000 restricted shares of Cardigant’s common stock. Simultaneous with the reverse merger, all the remaining assets and operations of Cardigant were spun-off.

    As a result of the reverse merger, Takung is now the sole wholly-owned operational subsidiary of Cardigant Takung management has taken over management of Cardigant.

    “The successful completion of the merger represents a major milestone for Takung, positioning the company for growth and access to the capital market,” said Benjamin Tan, Partner who led the Sichenzia Ross Friedman Ference LLP team. “It is our honor and privilege to be instrumental in the reverse merger and wish Takung all the very best.”

    About Sichenzia Ross Friedman Ference LLP

    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook page.

    Towerstream Corporation Announces $35.0 Million Secured Financing

    towerstream

    New York, NY – October 27, 2014 – Global Newswire – New York based securities law firm Sichenzia Ross Friedman Ference LLP announced that it has represented Towerstream Corporation in a five-year, $35 million secured debt financing agreement with affiliates of Melody Capital Partners, LP.

    As part of the financing, Towerstream issued warrants to purchase 3,600,000 shares of common stock of which two-thirds of the warrants will have an exercise price of $1.26 and one-third will have an exercise price of $0.01. The Sichenzia Ross Friedman Ference LLP team was led by partner Harvey J. Kesner, Counsel Ed Schauder and Associate Avital Even-Shoshan.

     

    Media Contact:
    pr@srfkllp.com

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Again Ranked As #1 PIPE Issuer Law Firm for 2014

    New York, NY – (October 9, 2014) – Sichenzia Ross Friedman Ference LLP led the national PIPE league tables in the first three quarters of 2014 by ranking #1 as the most active issuer counsel in the industry-standard DealFlow Report and in PlacementTracker’s PIPE Market League Tables. Since 2004, when the firm was initially ranked as the #1 PIPE U.S. law firm, Sichenzia Ross has consistently maintained its position at the top of the national rankings. Additionally, Sichenzia Ross ranked as the fourth most active investor counsel and the seventh most active placement agent counsel for the first nine months of 2014.The DealFlow Report ranking reflects the strong position that Sichenzia Ross has been able to maintain in the market over the past year. In the first three quarters of 2014, the firm has represented 33 issuers in transactions totaling over $253 million.Additionally, Sichenzia Ross was ranked 1st in 2014 for issuer counsel transactions by Placement Tracker, a project of Sagient Research. According to Sagient, in the first three quarters of 2014, Sichenzia Ross has advised issuers on 23 transactions amounting to over $141 million.


    *PIPEs Rankings are measured by the number of placements advised according to The DealFlow Report. Rankings include only PIPE transactions that have a value of at least $1.0 million. Visit the Sagient Research’s PlacementTracker’s League Tables to learn more about the PIPE Industry Tables.
    Media Contact:
    pr@srfkllp.com


    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises Single Touch on a $11.0 M Debt and Equity Financing Consisting of a $10.0 M Secured Financing and a $1.0 M PIPE with Fortress Investment Group

    sito - single touch interactive

    New York, NY – Oct 8, 2014 – GLOBAL NEWSWIRE – New York based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Single Touch Interactive, Inc. (OTC BB: SITO), a mobile media solutions provider, in a $11 million debt and equity financing where Single Touch secured a PIPE investment equaling $1 million in equity and $10 million in secured debt.

    As part of the investment, Single Touch will issue 2,619,539 shares of its common stock valued at $0.3817 per share. The Sichenzia RossFriedman Ference LLP  team was led by Partner Gregory Sichenzia, Marcelle Balcombe and Counsel Peter DiCharia.

    Media Contact:

    pr@srfkllp.com

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Eight Sichenzia Ross Attorneys Named Super Lawyers & Rising Stars

    2014 winners big

    (From left to right: Stephen A. Cohen, Tara Guarneri-Ferrara, Gary Emmanuel, James M. Turner, Michael H. Ference,    A. R. John Hitchings, Harvey Kesner, Sameer Rastogi)

    NEW YORK, NY–(Global Newswire October 7, 2014) – Sichenzia Ross Friedman Ference LLP (SRFF) is pleased to announce that three of the firm’s attorneys have been named 2014 New York Metro Super Lawyers. Additionally, four attorneys have been named 2014 New York Metro Rising Stars. Each year, no more than five percent of attorneys are selected for the prestigious Super Lawyers recognition and no more than 2.5 percent of attorneys are named Rising Stars.

    “We are delighted to be recognized for this prominent honor and we are proud of our outstanding attorneys,” said Gregory Sichenzia, senior partner at Sichenzia Ross.

    The Sichenzia Ross 2014 Super Lawyers are:

    • Michael H. Ference, Securities Litigation Partner
    • Harvey Kesner, Securities & Corporate Partner
    • Sameer Rastogi, Securities Litigation Partner

    The Sichenzia Ross 2014 Rising Stars are:

    • Stephen A. Cohen, Securities & Corporate Associate
    • Gary Emmanuel, Securities & Corporate Associate
    • Tara Guarneri-Ferrara, Securities & Corporate Associate
    • A. R. John Hitchings, Securities Litigation Associate
    • James M. Turner, Securities and Corporate Partner

    A list of these attorneys will appear in the October 2014 issue of the New York Metro Super Lawyers Magazine as well as in the New York Metro Super Lawyers special supplement of The New York Times.

    To read more about the 2014 Super Lawyers and Rising Stars Lists, please visit www.superlawyers.com.

    About Sichenzia Ross Friedman Ference LLP

    Sichenzia Ross Friedman Ference LLP is headquartered in New York City and offers a full range of financial and business legal services. SRFF specializes in advising business entities on all securities matters including public offerings, private investment in public entities (PIPEs) deals and international reverse merger transactions. SRFF is also nationally recognized as a leading firm for representation of broker-dealers and securities industry professionals in SEC and FINRA enforcement proceedings as well as securities litigation and arbitration. The Firm is a recognized leader in PIPEs transactions for publicly traded companies and has completed over 400 deals to date, totaling over $2.5 billion since 2001. SRFF maintains dedicated international corporate practice groups and is acknowledged for legal excellence, sectorial expertise and a strong commitment to innovation and client service.

    For more information, visit www.srff.com. For interview and media requests, contact Holly Artz at 212-930-9700

    Sichenzia Ross Friedman Ference LLP Advises Rightscorp, Inc. on a $2.65M PIPE Offering

    rightscorp

    NEW YORK, SEPT. 25, 2014 (GLOBE NEWSWIRE) — New York based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Rightscorp, Inc. (OTC QB: RIHT), a provider of monetization services for artists and holders of copyrighted intellectual property, on a $2.65 million private financing. The offering consisted of a sale of 10,608,000 shares of the company’s common stock and warrants to purchase 15,912,000 shares of common stock at $0.25 per Unit for a total offering of $2,652,000. The Sichenzia Ross Friedman Ference LLP team was led by Partner Gregory Sichenzia and Of Counsel Henry Nisser.

    Media Contact

    pr@srfkllp.com

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises Citius Pharmaceuticals, LLC on a Reverse Merger and $2.04 Million Pipe Financing

    citius pharma

    September 18, 2014 (GLOBE NEWSWIRE) – New York – based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Citius Pharmaceuticals, LLC (OTCQB: CTXR) – a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets- in connection with a Share Exchange and Reorganization Agreement between Citius Pharmaceuticals, LLC, Citius Pharmaceuticals, Inc. (formerly known as Trail One. Inc.) and the beneficial holders of the membership interests of Citius.

    Pursuant to the “Exchange Agreement”, Citius Pharmaceuticals, Inc. issued common stock to the holders of the membership interests of Citius representing approximately 72.0% of the outstanding shares of common stock.

    In connection with the “Exchange Agreement”, Sichenzia Ross advised Citius on a private offering whereby Citius sold 3,4000,067 Units for a purchase price of $0.60 per Unit for a total value of $2.04 million. Each Unit sold consisted of one share of common stock and a five-year warrant. The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia and Arthur S. Marcus.

    Media Contact:

    pr@srfkllp.com

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross in the news: “Three things that could go wrong with Alibaba IPO” (CNBC)

    Three things that could go wrong with Alibaba IPO

     

    There are any number of reasons to find Alibaba alluring: a global footprint, scads of cash and ownership that has its eyes focused firmly on future growth. That doesn’t mean, though, that the glittery initial public offering, which prices Thursday evening, is all gold. Indeed, there are at least three potential drawbacks investors should consider before banging at the door Friday to get a piece of what very likely will be the largest IPO ever.

    1. It plays in China, but will it play in the U.S., too?

    China-based Alibaba’s sales over the past year totaled nearly $300 billion, which dwarfs U.S. competitors like Amazon and eBay. But there’s still that nagging worry over whether it will connect with U.S. consumers, who in the past have been less than willing to buy into Chinese retailers of any sort.

    “We think it’s going to be challenging for them to gain a lot of traction, at least directly, with Western and particularly U.S. consumers,” Scott Kessler, equity analyst at S&P Capital IQ, said in an interview. Indeed, there is a long and unpleasant history for Chinese companies in the West, whether it’s with consumers or investors. Publicly traded Chinese stocks gained just 7.9 percent from 1993 to 2013, a time when U.S. stocks returned 555 percent, according to calculations recently reported by The Associated Press.

    “Just because the Western world is largely untapped for (Alibaba), suddenly there seems to be this massive potential,” Kessler added. “While that may be the case in some respects, we think it’s been very difficult for Chinese companies to make major inroads with Western and specifically U.S. consumers.”

    2. And then there’s that whole China thing

    Because of a long history of financial curiosities, Chinese companies carry their own special cloak of mystery. For Alibaba, it’s a little different, but still enough to give pause. No one is challenging the company’s riveting sales or profit figures, but there is some concern about the way Alibaba is headquartered in China but incorporated in the Cayman Islands. It’s certainly not the first company to do that—China prevents foreign ownership of company assets—but there are still some unique challenges.

    For one, investors won’t own common shares, they’ll actually be buying American depositary receipts. FinancialWeb does a nice job of explaining the potential issues here:

    One of the disadvantages of investing in an ADR is a lack of information. There is not as much information available about many foreign companies as there tends to be about domestic companies. This can increase your risk as an investor.Another disadvantage of investing in an ADR is that you have to worry about political conditions in the country where the company is located. This can add another layer of risk for you to be concerned with.

    “Political conditions” in China obviously can be tenuous, but hopes are that Alibaba can overcome any China-related stigma.

    “This may signify a born-again trust in Chinese companies, at least in the big bulge-bracket scale,” said Gregory Sichenzia, an IPO and securities lawyer with Sichenzia Ross Friedman Ference in New York. “What we’re hoping to see is that Alibaba does restore some confidence in investing in Chinese companies.

    3. Of course, there’s been just a little bit of … HYPE!!!!

    Yes, if you haven’t seen the headlines, Wall Street’s a little excited over this one, and we know these things don’t always end well. They don’t always begin so well, either.

    In fact, Alibaba itself is highly conscious of the 2012 Facebook debacle, arguably the host-hyped IPO ever. The social network’s market debut was a disaster: Nasdaq failed to get trading off on time, underwriter Morgan Stanley priced the shares at the top of the expected range then had to scramble just to get the stock to break even on the opening day, and investors dumped Facebook shares for months after.

    “The price seems to be creeping up every day,” Sichenzia said. “It’s getting expensive even as we speak, before it trades, which scares me a little bit. There is a lot of hype here. There is going to be a little bit of a bubble.” Alibaba took the unconventional step of listing a big tech company on the New York Stock Exchange instead of the Nasdaq. For that reason, and the Cayman Islands issue, Alibaba will not be included in most major indexes and thus most big exchange-traded funds, potentially limiting its liquidity.

    Securities lawyer Andrew Stoltmann warned investors to consider all the potential pitfalls.”Investors should steer clear of the Alibaba IPO despite the breathtaking pitches of near-certain riches by their financial advisers and stockbrokers,” he said. “Thousands of investors have been burned and scammed by believing the hype when it comes to Chinese companies. Alibaba might be the next one to lure unsuspecting investors into large losses.”

    CNBC Interviews Sichenzia Ross Partner Gregory Sichenzia: “Alibaba won’t pull page from Facebook IPO, but is it safe?”

    forwebsite


    September 16, 2014
    : CNBC interviewed Sichenzia Ross Friedman Ference LLP’s senior partner Gregory Sichenzia regarding possible legal implications of Alibaba’s upcoming initial public offering on the New York Stock Exchange. CNBC asked how Alibaba’s corporate domicile in the Cayman Islands could potentially affect investors; to which Sichenzia answered “If things go bad, the claim is against the Cayman company,” he said. “For an investor, it could be very frustrating to enforce your rights.” Visit here to read the rest of the article.

    Sichenzia Ross Friedman Ference LLP Advises Labor Smart, Inc. on a $1.1 million Private Placement of Common Stock.

    laborsmart

    August 18, 2014 (GLOBE NEWSWIRE) – New York – based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Labor Smart, Inc. (OTCBB: LTNC), a provider of on-demand construction, manufacturing and retail staffing , in a $1.1 million private placement pursuant of Regulation D. The transaction consisted of original issue discount debentures convertible at $0.15 per share and 100,000 shares of common stock. The Sichenzia RossFriedman Ference LLP  team was led by Gregory Sichenzia and Jeff Cahlon.

    About Sichenzia Ross Friedman Ference LLP

    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook page.

    Sichenzia Ross Friedman Ference LLP Acted as Lead Investor Counsel on VBI Vaccines’ $5.25 million private placement

    Securities Law Firm | Sichenzia Ross Friedman Ference LLP

    vbi vaccines

    NEW YORK, August 1, 2014 (GLOBE NEWSWIRE) – New York – based securities law firm, Sichenzia Ross Friedman Ference LLP announces that it represented the lead investor in a $5.25 million private placement conducted by VBI Vaccines Inc. (NASDAQ: VBIV), formerly Paulson Capital (Delaware) Corp. The offering, which originally closed into escrow on July 25, 2013, consisted of the sale of one unit of VBI’s securities, made up of shares of Common Stock, Series A Preferred Stock and two class of warrants exercisable into shares of VBI’s Series B Preferred Stock. The release of the funds and securities in escrow was subject to certain conditions precedent which was satisfied on July 25, 2014, at which time the funds and securities were released.

    VBI Vaccines, Inc. is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. The Sichenzia Ross Friedman Ference LLP team was led by partner Harvey Kesner and associate Tara Guarneri-Ferrara.

    Media Contact
    pr@srfkllp.com
    212-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises Intellect Neurosciences, Inc. on $1.2 Million PIPE offering

    intellect neurosciences

    Intellect_NeurosciencesNew York, July 31, 2014 (Global Newswire) – New York based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Intellect Neurosciences, Inc. (ILNS: OTC US) on a $1.2 million private placement consisting of Series F Preferred Stock and Warrants. Intellect Neurosciences Inc. is a biopharmaceutical company engaged in the discovery and development of disease modifying therapeutic agents for the treatment and prevention of Alzheimer’s disease. The Sichenzia Ross Friedman Ference LLP team was led by partner Arthur Marcus.

     

    Media Contact:
    pr@srfkllp.com
    (212)-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises Tonix Pharmaceuticals on $7.8 Million Public Offering

    tonix pharmaceuticals

    NEW YORK, July 16, 2014 (GLOBE NEWSWIRE) –New York based securities law firm, Sichenzia Ross Friedman Ference LLP, acted as counsel to Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP), a clinical-stage pharmaceutical company focused on researching common disorders of the central nervous system, on a recently completed $7.8 million registered direct public offering pursuant to Tonix’s shelf registration statement. The offering consisted of 657,000 shares of common stock sold at $11.90 per share. Roth Capital Partners acted as the sole placement agent in this offering. The Sichenzia Ross Friedman Ference LLP team consisted of partners Marc J. Ross and James M. Turner and associate Sharon Carroll.

    Media Contact
    pr@srfkllp.com
    (212)-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises J.P. Turner & Company on $2.1 Million Private Placement for Nanox Imaging PLC

    nanox

    NEW YORK, July 2, 2014 (GLOBE NEWSWIRE) – New York based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented J.P. Turner & Company as the sole placement agent on a $2.1 Million private placement of the ordinary shares of Nanox Imaging PLC.

    Nanox Imaging PLC is a company incorporated and registered in Gibraltar that is developing a product to replace the current, century-old, “Hot Cathode” X-Ray technology with “Cold Cathode” technology. The Sichenzia Ross Friedman Ference LLP team was led by partners Gregory Sichenzia, Tom Rose and David Manno.

    Media Contact
    pr@srfkllp.com
    212-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sicheniza Ross Friedman Ference Advises Cell Source Ltd. on Reverse Merger

    cell source

    NEW YORK, July 1, 2014 (GLOBE NEWSWIRE)
    New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Cell Source Limited (Israel) in a reverse merger transaction whereby Cell Source Inc., a Nevada based publicly traded company under the symbol “CLCS: OTCQB”, acquired 100% of the capital stock of Cell Source Limited, an Israeli biotechnology company engaged in developing cell therapy treatments.

    This past February, Sichenzia Ross represented Cell Source Limited in a private placement transaction consisting of 4.8 million units of securities raising approximately $3.6 million. Each unit consisted of one share of common stock and one common stock purchase warrant.

    The Sichenzia Ross Friedman Ference LLP team was led by partner Gregory Sichenzia, David Manno and associate Jay Yamamoto.

    Sichenzia Ross Media Contact:
    pr@srfkllp.com
    212-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Represents MusclePharm Corporation In An Endorsement Deal with Tiger Woods

    musclepharm logo

    On June 18, 2014, SRFF’s client, MusclePharm Corporation (OTCBB: MSLP), announced an endorsement deal with legendary golfer Tiger Woods. Under the terms of the agreement, the MusclePharm logo will appear on Mr. Wood’s golf bag and Mr. Woods will serve as a brand ambassador for the company.

    Sichenzia Ross’s Sports and Entertainment Law Practice Group represented MusclePharm in connection with the preparation and negotiation of this endorsement agreement. The transaction was led by SRFF attorneys Ed Schauder, Harvey Kesner and Tim O’Brien.

    In addition to the MusclePharm transaction with Mr. Woods, in the past 12 months, the Sichenzia Ross Friedman Ference LLP Sports and Entertainment Law Practice Group has consummated numerous transactions that have involved well-known athletes and celebrities including Governor Arnold Schwarzenegger, Mariano Rivera, Carmelo Anthony, Patrick Ewing, Mike Tyson, the Joe DiMaggio Estate, Chris Paul, Don Larsen, the 1994 New York Rangers, Andy Pettitte and Joe Torre. The group has also recently advised Steiner Sports in connection with its sponsorship and partnership agreements with the New York Yankees, Madison Square Garden, the Brooklyn Nets, the Boston Red Sox and Syracuse University.

    For more information on MusclePharm, visit their website at www.musclepharm.com.

    For more information about Sichenzia Ross Friedman Ference LLP’s Sports & Entertainment Law Practice Group contact Ed Schauder at (212) 930-9700 or visit the Firm’s website at www.srff.com.

    Sichenzia Ross Friedman Ference LLP Advises NTS Inc. on $140.0 Million Acquisition Transaction

    nts incorporated

    NEW YORK, June, 6, 2014 (GLOBE NEWSWIRE) –New York based securities law firm Sichenzia Ross Friedman Ference LLP announced that it has acted as counsel to NTS Inc. (NYSE MKT LLC: NTS) in a merger transaction valued at approximately $140.0 million where Tower Three Partners LLC, a leading operationally oriented private equity firm, acquired all the capital stock of NTS Inc. for $2.00 per share. NTS is a provider of high speed broadband services, including internet access, digital TV and other services to residential and business customers in northern Texas and southeastern Louisiana. The Sichenzia Ross Friedman Ference LLP team was led by partner Arthur Marcus and Of Counsel Henry Nisser. Mr. Marcus represented NTS, Inc. for more than seven years from its early days as a long distance provider in Israel to the present day, where it is an international telecommunications firm.

    Media Contact
    pr@srfkllp.com
    212-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises FreeSeas Inc. on $25.0 Million Public Offering of Preferred Stock and Warrants

    freeseas

    NEW YORK, June 5, 2014–New York- based securities law firm, Sichenzia Ross Friedman Ference LLP, advised FreeSeas Inc. (NASDAQ: FREE), a transporter of dry-bulk cargoes through the ownership and operation of a fleet of five Handysize and one Handymax vessels, in a recently completed $25 million registered direct public offering of Series D Convertible Preferred Stock and Series C Warrants. The securities consisted of one share of the Company’s Series D Convertible Preferred Stock and 184 Series C Warrants, exercisable for five years at an initial price of $1.42 per share. Each share of Series D Preferred Stock has a stated value of $100 and is convertible into a number of shares of common stock equal to $100 divided by $1.09. The Sichenzia Ross Friedman Ference LLP team was led by partners Marc J. Ross and James M. Turner.

    Media Contact
    pr@srfkllp.com
    212-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $20 Million Public Offering of Spherix Inc.

    spherix intellectual property

    NEW YORK, June 4, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Laidlaw & Company (UK) Ltd. as the sole placement agent in a $20 million public offering for Spherix, Inc. (NASDAQ: SPEX). The company offered a Series J preferred stock at a purchase price of $2.00 per share. Spherix Inc. is traded on the NASDAQ Capital Market under the trading symbol “SPEX”. The Sichenzia Ross Friedman Ference LLP team was led by partners Harvey Kesner, Richard A. Friedman and associates Tara Guarneri-Ferrara, and counsel Avital Even-Shoshan.

    Media Contact
    pr@srfkllp.com
    212-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises Drone Aviation Holding Corp. on Acquisition of Assets and $1.35 million PIPE Offering

    drone aviation

    NEW YORK, June, 4, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Drone Aviation Holding Corp. formerly known as Macrosolve (OTCQB: DRNE) in the acquisition of certain assets involved in the development of tethered drone based products. Simultaneously, Sichenzia Ross Friedman Ference LLP has represented Drone Aviation Holding Corp. on a $1.35 million private placement consisting of preferred stock and warrants at a purchase price of $.50 per unit. Drone Aviation Holding Corp. is a producer of drone applications. The Sichenzia Ross Friedman Ference LLP team was led by partner Gregory Sichenzia, Harvey Kesner and associate Tara Guarneri-Ferrara.

    Media Contact
    pr@srfkllp.com
    212-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises Zenovia Digital Exchange Corp. on $5 Million Private Placement Transaction

    zenovia

    June 4, 2014 – New York- based securities law firm, Sichenzia Ross Friedman Ference LLP, acted as counsel to Zenovia Digital Exchange Corp., a company that provides a Software as a Service-based technology platform for advertisers to access viewable media from publishers worldwide, in its recently completed private placement of units consisting of secured notes and warrants. The company raised an aggregate of $5.0 Million. Aegis Capital Corp. acted as the placement agent in the offering. The Sichenzia Ross Friedman Ference LLP team was led by partners Tom Rose and Marcelle Balcombe.

    Media Contact

    pr@srfkllp.com
    212-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Friedman Ference LLP Advises Vuzix Corporation on a $3 Million PIPE Offering

    vuzix

    NEW YORK, June 3, 2014 (GLOBE NEWSWIRE) — New York based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Vuzix Corporation (OTCQB: VUZI) on a $3 million private placement consisting of convertible 5% secured promissory notes, convertible at $2.25 per share. Vuzix Corporation is engaged in the design, manufacture, marketing and sale of wearable Video Eyewear products for use as an alternative private display solution in markets where portability and high resolution are key. The Sichenzia Ross Friedman Ference LLP team was led by partner Gregory Sichenzia and Peter DiChiara.

    CONTACT:

    Sichenzia Ross Friedman Ference LLP
    Gregory Sichenzia
    212-930-9700
    gsichenzia@srfkllp.com

    Gregory Sichenzia, Esq.

    Gregory Sichenzia, Esq.

    Gregory Sichenzia, a founding member, counsels public and private companies in all securities laws matters, from complex financing transactions and listings on various stock exchanges through everyday regulatory requirements. He has also been responsible for structuring innovative merger and acquisition transactions. Throughout his career he has represented many companies and investment banks in initial public offerings of securities, and has represented numerous public companies in private equity financing transactions (“PIPEs”) and the resulting resale regist
    Gregory Sichenzia, Esq.

    Latest posts by Gregory Sichenzia, Esq. (see all)

      Sichenzia Ross Friedman Ference LLP Advises Calpian Inc. on $8.3 Million Private Placement of Common Stock and Warrants

      calpian

      May 27, 2014 (GLOBE NEWSWIRE) – New York-based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Calpian Inc. (OTCQB: CLPI), a global processing and mobile payments technology company, on a private placement offering of units in the aggregate amount of $8.3 million. Each unit consisted of one share of common stock and a warrant to purchase one fifth of one share of common stock, priced at $1.00 per unit. The warrants are exercisable at $1.25 per share. National Securities acted as the lead placement agent. The Sichenzia Ross  Friedman Ference LLP team was led by partner Darrin M. Ocasio and associate Jay Yamamoto.

      Media Contact
      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Sorrento Therapeutics, Inc. on $25.0 million Public Offering of Common Stock

      sorrento

      NEW YORK, May 20, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Sorrento Therapeutics, Inc. (NASDAQ: SRNE), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, in a $25.0 million public offering. The offering consists of 4,765,000 shares of common stock priced at $5.25 per share. The Sichenzia Ross Friedman Ference LLP team was led by partners Jeff Fessler and Marcelle Balcombe.

      Media Contact
      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Genius Brands International, Inc. on $6.0 million PIPE Offering

      genius brands

      NEW YORK, March 26, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Genius Brands International, Inc. (GNUS. OTCQB) on a $6.0 million private placement of Series A Convertible Preferred Stock with a conversion price of $2.00 per share. Genius Brands is multimedia content and brand management company. Chardan Capital Markets LLC acted. as sole placement agent for the offering. The Sichenzia Ross Friedman Ference LLP team was led by partners Harvey Kesner and associate Tara Guarneri-Ferrara.

      Media Contact:

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $10 million Private Placement of Relmada Therapeutics, Inc.

      relmada

      NEW YORK, May 12, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Laidlaw & Company (UK) Ltd. as sole Placement Agent in a $10 million Private Placement offering for Relmada Therapeutics, Inc., a privately held company. The offering was of Units consisting of Common Stock and Class A and B Warrants. The Sichenzia Ross Friedman Ference LLP team was led by partners Richard Friedman and Stephen Cohen.

      Media Contact:

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Marathon Patent on $6.5 million PIPE Offering

      marathon

      NEW YORK, May 5, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Marathon Patent Group, Inc. (OTCBB: MARA) on a $6.5 million private placement of units consisting of Series A Preferred Stock and warrants at a unit price of $6.50 per unit. Marathon is an intellectual property services and monetization company. Laidlaw & Company (UK) Ltd. as sole placement agent for the offering. The Sichenzia Ross Friedman Ference LLP team was led by partners Harvey Kesner and Counsel Edward Schauder.

      Media Contact:
      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises AV Therapeutics, Inc. on $1.26 million PIPE Offering

      av therapeutics

      NEW YORK, April 30, 2014 (GLOBE NEWSWIRE) — New York based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented AV Therapeutics, Inc. (OTCQB:AVTH) on a $1.26 million private placement of units consisting of common stock and warrants at a unit price of $0.20. AV Therapeutics, Inc. is engaged in the business of developing cancer therapeutics and immunotherapeutic vaccines that can be used alone or in combination with prevalent treatment modalities such as chemotherapy and radiation to treat active disease and to prevent metastases and recurrence. The Sichenzia Ross Friedman Ference LLP team was led by partner Darrin M. Ocasio.

      Media Contact:

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises J.P. Turner & Company, L.L.C on $ 2.5 million Private Placement of X2 Bio Systems, Inc..

      xz biosystems

      NEW YORK, April 18, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented J.P. Turner & Company as sole Placement Agent in a $2.5 million private placement of X2 Bio systems, Inc., a privately held Seattle based science and technology company which is developing the first complete solution for assessing sport brain injuries. The offering consisted of $2.5 million of Units consisting of 6% convertible promissory notes and common stock purchase warrants. The Sichenzia Ross Friedman Ference LLP team was led by partners Gregory Sichenzia and David Manno.

      Media Contact:

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Conkwest, Inc. on $7.06 million Private Placement of Units consisting of Series C Convertible Preferred Stock and Warrants to Purchase Common Stock.

      conkwest

      NEW YORK, April 11, 2014 (GLOBE NEWSWIRE) – New York – based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Conkwest, Inc. in a $7.06 million private placement of the Preferred Stock and Warrants of Conkwest, Inc., a privately held company which is involved in the development of immunotherapeutic treatments for cancers and debilitating viral infections using targeted cancer killing cell-lines. continue reading >>

      Sichenzia Ross Friedman Ference LLP Advises Aegis Capital Corp. on $2.1 million Secondary Public Offering of Intellicheck Mobilisa, Inc.

      intellicheck mobilisa

      NEW YORK, April 9, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Aegis Capital Corp. as sole underwriter in a $2.1 million secondary public offering for Intellicheck Mobilisa (“IDN” NYSE MKT. The underwriting was pursuant to a prospectus supplement to an effective S-3 registration statement. The offering consisted of 2,617,000 shares at an offering price of $.80 per share. The Sichenzia Ross Friedman Ference LLP team was led by partners Gregory Sichenzia and Marcelle Balcombe.

      Media Contact:

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $10 million Secondary Public Offering of Cyclacel Pharmaceuticals, Inc.

      cyclacel

      NEW YORK, April 8, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Laidlaw & Company (UK) Ltd. as sole underwriter in a $10 million secondary public offering for Cyclacel Pharmaceuticals, Inc. (“CYCC.” NASDAQ). The underwriting was pursuant to a prospectus supplement to an effective S-3 registration statement. The offering consisted of 2,857,143 shares of common stock at an offering price of $3.50 per share. The Sichenzia Ross Friedman Ference LLP team was led by partners Richard Friedman and Stephen Cohen.

      Media Contact:

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Spherix Incorporated on $4.4 million PIPE Offering

      spherix intellectual property

      NEW YORK, March 26, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Spherix Incorporated (SPEX. NASDAQ) on a $4.4 million private placement of units consisting of Common Stock and warrants at a unit price of $3.75. Spherix is an intellectual property company that owns patented and unpatented intellectual property. Laidlaw & Company (UK) Ltd. as sole placement agent for the offering. The Sichenzia Ross Friedman Ference LLP team was led by partners Harvey Kesner and associate Tara Guarneri-Ferrara.

      Media Contact:

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $6.72 million Secondary Public Offering of Novabay Pharmaceuticals, Inc.

      novabay pharma

      NEW YORK, March 25, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Laidlaw & Company (UK) Ltd. as sole underwriter in a $6.72 million secondary public offering for Novabay Pharmaceuticals, Inc. (“NBY” NYSE MKT). The underwriting was pursuant to a prospectus supplement to an effective S-3 registration statement. The offering consisted of 5,600,000 shares of common stock and 18 month warrants to purchase 1,400,000 shares of common stock at combined offering price of $1.20 . The Sichenzia Ross Friedman Ference LLP team was led by partners Richard Friedman and Stephen Cohen.

      Media Contact:

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Brean Capital LLC on $ 6.5 million Registered Direct Offering of ClearSign Combustion Corporation

      clearsign

      NEW YORK, March 5, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Brean Capital LLC. as sole Placement Agent in a $6.5 million registered direct offering for ClearSign Combustion Corporation (“CLIR” NASDAQ). The offering was pursuant to a prospectus supplement to an effective S-3 registration statement. The offering consisted of 812,500 shares at an offering price of $8.00 per share. The Sichenzia Ross Friedman Ference LLP team was led by partner Jay Kaplowitz and associate Stephen Cohen

      Media Contact:

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Represents Tonix Pharmaceuticals in $43.5 Million Shelf Takedown

      tonix pharmaceuticals

      SRFF Named-Partner, Marc J. Ross, Leads Transaction Whose Proceeds Will fund Development of Medications for the Treatment of Fibromyalgia and Post-Traumatic Stress Disorder

      NEW YORK CITY – February 12, 2014 Sichenzia Ross Friedman Ference LLP (SRFF), a leading corporate securities law firm headquartered in New York City, announces it represented Tonix Pharmaceuticals Holding Corp. (TNXP) in the closing of its confidentially marketed public offering, resulting in aggregate gross proceeds of approximately $43.5 million. The shelf takedown, which closed January 29, 2014, was led by SRFF named partner Marc J. Ross.

      The SRFF team, which in addition to Ross as lead counsel included firm partner James M. Turner, advised Tonix in the underwritten public offering of 2,898,550 shares of the common stock at a price of $15.00 per share. Roth Capital Partners acted as the sole book-running manager for the offering and National Securities Corporation, a wholly owned subsidiary of National Holdings, Inc. (NHLD), acted as co-manager. Tonix granted the underwriters a 45-day option to acquire an additional 434,782 shares to cover overallotments in connection with the offering.

      Tonix Pharmaceuticals develops prescription medications for disorders of the central nervous system, targeting conditions characterized by significant unmet medical needs, inadequate existing treatment options, and high dissatisfaction among both patients and physicians. Tonix expects to use the net proceeds of the offering to support the continued development of TNX-102 SL for the treatment of fibromyalgia, to initiate clinical trials of TNX-102 SL for the treatment of post-traumatic stress disorder, and to initiate clinical trials of TNX-201 for tension-type headache.

      Avista Capital Partners

      Last modified: 2013-12-16T13:14:39Z

      Copyright 2013 . All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

      Media Contact:

      pr@srfkllp.com
      (212) 930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Xenetic Biosciences in Reverse Merger and Direct PIPE Investment.

      xenetic biosciences

      SRFF Team Led by Named-Partner, Marc J. Ross, Succeeds in Leveraging Unique Solution and Direct PIPE Investment Totaling $10 million

      NEW YORK CITY – February 12, 2014. Sichenzia Ross Friedman Ference LLP (SRFF), a leading corporate securities law firm headquartered in New York City, represented UK-based Xenetic Biosciences PLC. (XEN), in connection with it’s reverse merger transaction with Xenetic Biosciences Inc., (GAIFD) in addition to a direct PIPE investment equaling $10 million in equity from Baxter International.

      The SRFF team, which in addition to the firm’s named partner, Marc J. Ross as lead counsel included firm partner James M. Turner, leveraged a unique solution that hinged on a Section 3(a)(10) exemption. Companies headquartered outside the United States but desiring entrance into a reverse merger transaction into a U.S.- listed company such as Xenetic Biosciences Ltd. confront a significant issue that arises in the execution of how the securities will be issued.

      Ross advised Xenetic Biosciences PLC in connection with the Scheme of Arrangement, a court-reviewed and approved transaction between a company and its shareholders whereby the court approves the fairness of the terms and conditions of the exchange of shares. In this Scheme, Xenetic was acquired by Nevada-based General Sales and Leasing; in connection with this acquisition, General Sales and Leasing changed its name to Xenetic Biosciences, Inc., and its ticker symbol.

      In this series of transactions, the holders of all of the capital stock of Xenetic UK exchanged their shares for a total of 132,545,504 newly-issued shares of Xenetic Biosciences Inc. common stock; SRFF attorneys Ross and Turner additionally assisted the company in raising $10 million from Baxter International.

      Avista Capital Partners

      Last modified: 2013-12-16T13:14:39Z

      Copyright 2013 . All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

      Media Contact:

      pr@srfkllp.com
      (212) 930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      SRFF Ranked Number One PIPE Issuer Law Firm for the Second Quarter of 2014

      New York, NY (July 17, 2014 ) – Sichenzia Ross Friedman Ference has again been ranked the number one PIPE issuer law firm in the nation for the second financial quarter of 2014 (April, May and June of 2014), as ranked by the industry-standard DEAL FLOW REPORT* . Since 2004, when the firm was initially ranked as the #1 PIPE law firm nationwide, Sichenzia Ross has completed approximately 500 such transactions valued at more than $3.0 billion, making it the #1 overall ranked firm for the period. The DEAL FLOW REPORT ranking reflects the strong position that Sichenzia Ross has been able to maintain in the market over the past sixteen years.

      * PIPEs Rankings are measured by the number of placements advised according to The PIPEs Report and Privateraise.com. The rankings include only PIPE transactions that have a value of at least $1.0 million. For more information about PIPE rankings, go to www.privateraise.com.

      Media Contact

      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Friedman Ference LLP Advises Aegis Capital Corp. on $1.8 million Public Offering of CollabRX, Inc.

      collabNEW YORK, June 19, 2014 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Aegis Capital Corp. as the sole underwriter in a $1.8 million public offering for CollabRX, Inc. (NASDAQ: CLRX), a provider of cloud-based expert systems designed to inform healthcare decision-making. The underwriting was pursuant to a prospectus supplement to an effective S-3 registration statement. The offering consisted of 913,500 shares of common stock valued at $2.00 per share. The Sichenzia Ross Friedman Ference LLP team was led by partners Gregory Sichenzia, Marcelle Balcombe and associate Jeff Cahlon.

      Media Contact
      pr@srfkllp.com
      212-930-9700

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP

      Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

      Visit SRFK's LinkedIn page
      Sichenzia Ross Ference Kesner LLP

      Jeffrey J. Fessler named 2014 New York SmartCEO Attorney of the Year

      JFessler_LinkedInNEW YORK, June 24, 2014 (GLOBE NEWSWIRE) — New York SmartCEO Magazine, in conjunction with Citibank, has named Sichenzia Ross partner, Jeffrey J. Fessler the New York 2014 Attorney of the Year.

      The ESQ awards program was established to recognize the top attorneys who have made an outstanding impact on privately held companies. Fessler was chosen out of more than twenty finalists nominated regionally for the prestigious award. “SmartCEO’s dedication to the entrepreneurial and business community is impressive. I am grateful for their recognition and this is a great honor” Fessler said.

      According to SmartCEO, an independent committee of local business leaders selected Fessler after reviewing submissions sent in from the entire New York region. All of the award finalists were celebrated at a ceremony in June and will be profiled in the July/August issue of SmartCEO Magazine. Watch this event video to learn more about the award and Mr. Fessler.

      About Sichenzia Ross Friedman Ference LLP

      Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more, visit www.srff.com

      About SmartCEO

      SmartCEO is an exclusive community of CEOs and business executives, highly regarded mentors and well-respected thought leaders whose experiences benefit their organizations and the communities in which they serve. SmartCEO’s mission is to educate and inspire the business community through the pages of its award-winning magazine, connections at C-level events and access to valuable online resources. To learn more, visit www.smartceo.com

      Partners Gregory Sichenzia, Tom Rose and Associate Jay Yamamoto attend the NASDAQ Opening Bell with Fusion Telecommunications International Inc.

      NEW YORK, June 9, 2014–Senior partners Gregory Sichenzia, Tom Rose, associate Jay Yamamoto and Fusion Telecommunications International Inc. (NASDAQ: FSNN) celebrated Fusion’s inaugural trading day by ringing the Monday morning opening bell of the NASDAQ stock exchange. The NASDAQ stock market is the second largest stock exchange in the world by market capitalization. To learn more, watch the event video here

      goodone

      16th Anniversary of Sichenzia Ross Friedman Ference LLP – A History of Unwavering Excellence

      We are proud to announce that today marks the 16th anniversary of the founding of Sichenzia Ross Friedman Ference LLP. SRFF was founded in 1998, and all of its original founding partners are with the firm today. This commitment is echoed by the stability of our attorneys and our long-term relationships with our clients—some of which have been with SRFF since our inception. We are grateful for such deep-rooted client partnerships and for our enduring relationships with the New York City community and our supporters.

      Sichenzia Ross Friedman Ference LLP Again Ranked Number One PIPE Issuer Law Firm for 2014

      Firm Has Been the Nation’s Leader in PIPEs Transactions Since 2004

      Also Ranked Among the Leaders as Investor and Placement Agent Counsel

      New York, NY (April 24, 2014 ) – Sichenzia Ross Friedman Ference LLP (SRFF) has again been ranked the number one PIPE issuer law firm in the nation for YTD 2014, as ranked by the industry-standard DEAL FLOW REPORT. continue reading >>

      Sichenzia Ross Friedman Ference LLP Advises Scilex Pharmaceutical, Inc. on $5 Million Private Placement Transaction

      NEW YORK, March 20, 2014 – New York- based securities law firm, Sichenzia Ross Friedman Ference LLP, acted as counsel to Malvern Pa.-based Scilex Pharmaceuticals, Inc. a company engaged in transdermal delivery systems with its recently completed private placement of units consisting of common stock and warrants. The Company raised an aggregate of $5.0 Million. Aegis Capital Corp. acted as the placement agent the offering. The Sichenzia Ross Friedman Ference LLP team was led by Jeffrey Fessler and Marcelle Balcombe

      About Sichenzia Ross Friedman Ference LLP

      Sichenzia Ross Friedman Ference LLP are corporate and securities lawyers that provide experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world.